Literature DB >> 29730276

Mechanism of N6-methyladenosine modification and its emerging role in cancer.

Sicong Zhang1.   

Abstract

N6-methyladenosine (m6A), the most prevalent internal methylation in messenger RNA (mRNA) that is deposited by m6A methyltransferases, removed by m6A demethylases and recognized by different RNA-binding proteins, distinguishes the transcripts through multilayer interactions with mRNA processing, export, degradation and translation machineries. m6A plays an important role in regulation of gene expression for fundamental cellular processes and diverse physiological functions. Aberrant m6A decorations lead to cancer but also have the potential to yield new therapies. This review outlines the evolution of the m6A field, formation of key concepts, important open questions and also discusses the molecular basis of mRNA m6A modification and its effect in cancer, highlighting the potential of demethylase as a therapeutic target for cancer treatment.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cancer; Demethylase; Epitranscriptomics; Methyltransferase; N(6)-methyladenosine; m(6)A methylation

Mesh:

Substances:

Year:  2018        PMID: 29730276     DOI: 10.1016/j.pharmthera.2018.04.011

Source DB:  PubMed          Journal:  Pharmacol Ther        ISSN: 0163-7258            Impact factor:   12.310


  14 in total

1.  Pan-Cancer Study of SHC-Adaptor Protein 1 (SHC1) as a Diagnostic, Prognostic and Immunological Biomarker in Human Cancer.

Authors:  Jianlin Chen; Gan Gao; Limin Li; Junping Ding; Xianhua Chen; Jianfei Lei; Haihua Long; Lihua Wu; Xin Long; Lian He; Yongqi Shen; Jinzhong Yang; Yonggang Lu; Yifan Sun
Journal:  Front Genet       Date:  2022-05-02       Impact factor: 4.772

2.  m6A RNA modification and its writer/reader VIRMA/YTHDF3 in testicular germ cell tumors: a role in seminoma phenotype maintenance.

Authors:  João Lobo; Ana Laura Costa; Mariana Cantante; Rita Guimarães; Paula Lopes; Luís Antunes; Isaac Braga; Jorge Oliveira; Mattia Pelizzola; Rui Henrique; Carmen Jerónimo
Journal:  J Transl Med       Date:  2019-03-12       Impact factor: 5.531

3.  N6-Methyladenosine Regulates the Expression and Secretion of TGFβ1 to Affect the Epithelial-Mesenchymal Transition of Cancer Cells.

Authors:  Jiexin Li; Feng Chen; Yanxi Peng; Ziyan Lv; Xinyao Lin; Zhuojia Chen; Hongsheng Wang
Journal:  Cells       Date:  2020-01-25       Impact factor: 6.600

Review 4.  Functions of N6-methyladenosine and its role in cancer.

Authors:  Liuer He; Huiyu Li; Anqi Wu; Yulong Peng; Guang Shu; Gang Yin
Journal:  Mol Cancer       Date:  2019-12-04       Impact factor: 27.401

Review 5.  Current Advances in N6-Methyladenosine Methylation Modification During Bladder Cancer.

Authors:  Qiang Liu
Journal:  Front Genet       Date:  2022-01-11       Impact factor: 4.599

6.  The methylation modification of m6A regulators contributes to the prognosis of ovarian cancer.

Authors:  Wenjing Zhu; Long Zhao; Beihua Kong; Ying Liu; Xin Zou; Tongqin Han; Yongmei Shi
Journal:  Ann Transl Med       Date:  2022-01

7.  The m6A epitranscriptome opens a new charter in immune system logic.

Authors:  Zhonghua Ma; Xiangyu Gao; You Shuai; Xiaofang Xing; Jiafu Ji
Journal:  Epigenetics       Date:  2020-10-19       Impact factor: 4.861

8.  VIRMA-Dependent N6-Methyladenosine Modifications Regulate the Expression of Long Non-Coding RNAs CCAT1 and CCAT2 in Prostate Cancer.

Authors:  Daniela Barros-Silva; João Lobo; Catarina Guimarães-Teixeira; Isa Carneiro; Jorge Oliveira; Elena S Martens-Uzunova; Rui Henrique; Carmen Jerónimo
Journal:  Cancers (Basel)       Date:  2020-03-25       Impact factor: 6.639

9.  m6A-induced lncRNA MALAT1 aggravates renal fibrogenesis in obstructive nephropathy through the miR-145/FAK pathway.

Authors:  Peihua Liu; Bo Zhang; Zhi Chen; Yao He; Yongchao Du; Yuhang Liu; Xiang Chen
Journal:  Aging (Albany NY)       Date:  2020-03-23       Impact factor: 5.682

10.  Histone lactylation drives oncogenesis by facilitating m6A reader protein YTHDF2 expression in ocular melanoma.

Authors:  Jie Yu; Peiwei Chai; Minyue Xie; Shengfang Ge; Jing Ruan; Xianqun Fan; Renbing Jia
Journal:  Genome Biol       Date:  2021-03-16       Impact factor: 13.583

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.